Updates on postpartum hemorrhage: prediction, early detection and management

Postpartum hemorrhage (PPH) continues to pose a significant threat to maternal health worldwide, despite advancements in obstetric care. This article provides an overview of recent updates in the management of PPH, focusing on strategies aimed at enhancing outcomes and minimizing complications. Current guidelines underscore the importance of early identification and immediate intervention in the management of PPH. Machine learning models (MLMs), E-motive approach, estimation of serum fibrinogen levels and ABL estimation Active management protocols advocate for the administration of carbetocin and use of negative intrauterine pressure suction device in high-risk cases to mitigate blood loss. In cases where initial pharmacological interventions fail to control bleeding, alternative measures such as balloon tamponade or uterine artery embolization (UAE) may be necessary. Innovations like the Bakri balloon, NASG, UAE have revolutionized the management of atonic PPH by offering a non-surgical option for hemorrhage control. Permissive resuscitation, recombinant active factor seven (VIIa), desmopressin acetate (DDAVP) and lyophilized fibrinogen concentrate have proven to be beneficial in refractory PPH. Efforts are ongoing to develop less invasive techniques that prioritize maternal fertility and minimize morbidity. Furthermore, the integration of multidisciplinary teams and simulation training plays a pivotal role in enhancing PPH management.